WAY

Waystar Holding Corp. Common Stock
NASDAQHEALTHCAREHEALTH INFORMATION SERVICES

Key Statistics

Market Cap
$4.54B
P/E Ratio
34.33
EPS
$0.69
Beta
0.07
52W High
$41.47
52W Low
$17.26
50-Day MA
$20.51
200-Day MA
$27.02
Dividend Yield
Profit Margin
10.90%
Forward P/E
13.79
PEG Ratio

About Waystar Holding Corp. Common Stock

Waystar Holding Corp. The company is headquartered in Lehi, Utah.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$1.16B
Gross Profit (TTM)$794.87M
EBITDA$413.98M
Operating Margin25.60%
Return on Equity3.57%
Return on Assets3.31%
Revenue/Share (TTM)$6.33
Book Value$20.54
Price-to-Book1.13
Price-to-Sales (TTM)3.93
EV/Revenue4.978
EV/EBITDA13.94
Quarterly Earnings Growth (YoY)37.50%
Quarterly Revenue Growth (YoY)22.40%
Shares Outstanding$191.81M
Float$139.70M
% Insiders1.48%
% Institutions109.98%

Historical Volatility

HV 10-Day
48.76%
HV 20-Day
56.85%
HV 30-Day
55.74%
HV 60-Day
59.17%
HV Rank
70.2%

Volatility is currently contracting

Analyst Ratings

Consensus ($33.48 target)
5
Strong Buy
17
Buy
1
Hold

Latest News

Waystar Announces Appointment of Alpana Wegner as Chief Financial Officer

Accomplished technology CFO to help advance Waystar's growth strategy and value creation LEHI, Utah and LOUISVILLE, Ky., July 29, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced the appointment of Alpana Wegner as Chief Financial Officer, effective August 1, 2026.

PRNewsWire7/29/2026Neutral
Waystar Reports Second Quarter 2026 Results

Q2 revenue of $319.7M, up 18% YoY Q2 net income of $40.9M and non-GAAP net income of $83.3M Q2 net income margin of 13%; adjusted EBITDA margin of 43% Raising revenue and adjusted EBITDA guidance for 2026 LEHI, Utah and LOUISVILLE, Ky., July 29, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today reported results for the second quarter ended June 30, 2026.

PRNewsWire7/29/2026Neutral
Waystar Earns Overall "A" Rating from KLAS for Revenue Cycle Suites, Cementing Its Platform Advantage in a Fragmented Market

Report finds that clients using multiple Waystar capabilities achieve the strongest outcomes, highlighting the value of a single, connected platform LEHI, Utah and LOUISVILLE, Ky., July 21, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that it earned an overall "A" satisfaction score among revenue cycle management (RCM) platform vendors in KLAS Research's inaugural Revenue Cycle Management Suites 2026 report.

PRNewsWire7/21/2026Neutral
Waystar to Report Second Quarter 2026 Financial Results on July 29, 2026

LEHI, Utah and LOUISVILLE, Ky., July 15, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced it will report financial results for the second quarter ended June 30, 2026, after market close on Wednesday, July 29, 2026.

PRNewsWire7/15/2026Neutral
Waystar: Silently Taking Over Healthcare Billing

Waystar Holding Corp. is rated buy, with an 85% upside to a $37 price target, as current share price reflects temporary private equity (PE) selling pressure, not business fundamentals. Waystar's revenue grew 22% YoY, profit margins remain above 40%, and a $200M buyback offsets PE overhang; 23 of 24 analysts rate it Buy/Strong Buy. The Iodine acquisition and AI-powered AltitudeAI suite expand WAY's end-to-end billing solutions, driving new client wins and high retention in a $100B+ addressable market.

Seeking Alpha6/18/2026Positive
New Research Reveals Healthcare Leaders Who Unite Financial and Clinical Data Recover Millions in Previously Missed Revenue

Healthcare leaders show unanimous interest in a single AI-powered platform connecting the mid-cycle to the final claim — yet 86% are still leaving revenue on the table LEHI, Utah and LOUISVILLE, Ky., June 9, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today released The State of the Mid-Revenue Cycle report.

PRNewsWire6/9/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on WAY and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 7/29/2026